Analysis of glioblastoma tissues from The Cancer Genome Atlas (TCGA) database [17] demonstrated increased VEGFR-2 protein expression determined with reverse phase protein array in tumors with either copy number variations (CNV) or mutations in the PTEN gene compared with tumors without genetic alterations. This evidence concerns the gene PTEN and glioblastoma.